Industrializing Immuno-Oncology Therapeutic Discovery Platforms

PEGS Boston, Virtual
July 15, 2020

We present concrete use cases supporting large molecule and cellular therapeutics R&D, end-to-end. Our special focus is on in silico molecule assembly, on mono- to multispecific activity comparisons, developability assessments, and on the development and evaluation of CAR T cell lines. The platform shows unmatched flexibility in handling and exploring novel therapeutic modalities and supports increased efficiency and speed in their development, among other benefits.